News + Filings Transactions Holdings
|
Alta Partners VIII, L.P.
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Conversion | Common Stock | 589.7k | $0.00 | $0 | | 10/01/2018 |
10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Conversion | Common Stock | 458.3k | $0.00 | $0 | | 10/01/2018 |
10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Conversion | Common Stock | 382.7k | $0.00 | $0 | | 10/01/2018 |
10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Conversion | Common Stock | 514.2k | $0.00 | $0 | | 10/01/2018 |
10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Conversion | Series B Preferred Stock | 10.2M | $0.00 | $0 | | 10/01/2018 |
10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Conversion | Series C Preferred Stock | 12.4M | $0.00 | $0 | | 10/01/2018 |
10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Conversion | Series E Preferred Stock | 18.7M | $0.00 | $0 | | 10/01/2018 |
10/01/2018 | SUTRO BIOPHARMA, INC. | STRO | Conversion | Series D Preferred Stock | 9.4M | $0.00 | $0 | | 10/01/2018 |
07/23/2018 | Allakos Inc. | ALLK | Conversion | Common Stock | 11.3M | $0.00 | $0 | See footnote | 07/23/2018 |
07/23/2018 | Allakos Inc. | ALLK | Purchase | Common Stock | 250k | $18.00 | $4.5M | See footnote | 07/23/2018 |
07/23/2018 | Allakos Inc. | ALLK | Conversion | Series A Preferred Stock | 10M | $0.00 | $0 | See footnote | 07/23/2018 |
07/23/2018 | Allakos Inc. | ALLK | Conversion | Series B Preferred Stock | 1.2M | $0.00 | $0 | See footnote | 07/23/2018 |
12/30/2015 | Evofem Biosciences, Inc. | EVFM | Sale | Common Stock | 250k | $1.44 | $360k | | 12/28/2015 |
12/29/2015 | Evofem Biosciences, Inc. | EVFM | Sale | Common Stock | 493.7k | $1.53 | $755.3k | | 12/28/2015 |
12/28/2015 | Evofem Biosciences, Inc. | EVFM | Sale | Common Stock | 54.3k | $1.59 | $86.4k | | 12/28/2015 |
12/15/2015 | Evofem Biosciences, Inc. | EVFM | Sale | Common Stock | 529.3k | $1.44 | $762.1k | | 12/15/2015 |
06/08/2015 | ZS Pharma, Inc. | ZSPH | Sale | Common Stock | 11.2k | $57.53 | $644.3k | | 06/05/2015 |
06/05/2015 | ZS Pharma, Inc. | ZSPH | Sale | Common Stock | 164.2k | $57.88 | $9.5M | | 06/05/2015 |
06/04/2015 | ZS Pharma, Inc. | ZSPH | Sale | Common Stock | 39.5k | $57.21 | $2.3M | | 06/03/2015 |
06/04/2015 | ZS Pharma, Inc. | ZSPH | Sale | Common Stock | 48.9k | $57.71 | $2.8M | | 06/03/2015 |
06/03/2015 | ZS Pharma, Inc. | ZSPH | Sale | Common Stock | 23.2k | $56.60 | $1.3M | | 06/03/2015 |
06/02/2015 | ZS Pharma, Inc. | ZSPH | Sale | Common Stock | 84.3k | $56.77 | $4.8M | | 05/29/2015 |
06/01/2015 | ZS Pharma, Inc. | ZSPH | Sale | Common Stock | 72.5k | $58.00 | $4.2M | | 05/29/2015 |
05/29/2015 | ZS Pharma, Inc. | ZSPH | Sale | Common Stock | 124.9k | $58.63 | $7.3M | | 05/29/2015 |
05/29/2015 | ZS Pharma, Inc. | ZSPH | Sale | Common Stock | 14.7k | $59.69 | $877.2k | | 05/29/2015 |
05/12/2015 | aTYR PHARMA INC | LIFE | Conversion | Common Stock | 1.7M | $0.00 | $0 | | 05/12/2015 |
05/12/2015 | aTYR PHARMA INC | LIFE | Conversion | Common Stock | 92.3k | $0.00 | $0 | | 05/12/2015 |
05/12/2015 | aTYR PHARMA INC | LIFE | Conversion | Series B Redeemable Convertible Preferred Stock | 3.6M | $0.00 | $0 | | 05/12/2015 |
05/12/2015 | aTYR PHARMA INC | LIFE | Conversion | Series B-2 Redeemable Convertible Preferred Stock | 4.3M | $0.00 | $0 | | 05/12/2015 |
05/12/2015 | aTYR PHARMA INC | LIFE | Conversion | Series C Redeemable Convertible Preferred Stock | 4.4M | $0.00 | $0 | | 05/12/2015 |
05/12/2015 | aTYR PHARMA INC | LIFE | Conversion | Series D Redeemable Convertible Preferred Stock | 1.1M | $0.00 | $0 | | 05/12/2015 |
05/12/2015 | aTYR PHARMA INC | LIFE | Conversion | Series E Redeemable Convertible Preferred Stock | 893.7k | $0.00 | $0 | | 05/12/2015 |
02/18/2015 | Esperion Therapeutics, Inc. | ESPR | Other (disposition) | Common Stock | 842.2k | $0.00 | $0 | | 02/18/2015 |
12/10/2014 | TREVENA INC | TRVN | Purchase | Common Stock | 500k | $4.00 | $2M | Direct and Indirect - See Footnote | 12/10/2014 |
11/17/2014 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Other (disposition) | Common Stock | 1.5M | $0.00 | $0 | direct and indirect; see footnote | 11/17/2014 |
|
|